We verified that transcription factor ISL1 cooperated with demethylase KDM6B to upregulate lipid metabolizing enzyme SNAI1, so as to protect against improve NAFLD, including reducing the degree of hepatic steatosis, plasma lipid concentration, and lipid accumulation in cells. Here, MBD2 is linked to metabolic dysfunction-associated steatotic liver disease.